Afluria Quadrivalent 2017 - 2018 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 18 Years of Age and Above Prefilled Syringe 0.5 mL, 10/Pack Seqirus 33332031701

Afluria Quadrivalent 2017 - 2018 Flu Vaccine 60 mcg / 0.5 mL Indicated For People 18 Years of Age and Above Prefilled Syringe 0.5 mL, 10/Pack Seqirus 33332031701

TERMS & CONDITIONS FOR PURCHASING INJECTABLES & MEDICATIONS : 1- REGULATIONS ON PURCHASE OF INJECTABLES & MEDICATIONS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE. 2- INJECTABLES & MEDICATIONS WOULD BE SOLD ONLY TO QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , DENTAL OFFICES , HEALTH CARE PROVIDERS , .... ) WITH VALID MEDICAL LICENSE. 3- ORDERS INCLUDING PURCHSE OF INJECTABLES & MEDICATIONS WOULD BE PROCESSED AFTER VERIFICATION OF PURCHASER'S VALID MEDICAL LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )

Manufacturer # 33332031701 Brand Afluria® Quadrivalent 2017 - 2018 Manufacturer Seqirus USA Inc Application Flu Vaccine Container Type Prefilled Syringe Dosage Form Injection Generic Drug Code 43462 NDC Number 33332-0317-01 Storage Requirements Requires Refrigeration Strength 60 mcg / 0.5 mL Type Intramuscular User Indicated For People 18 Years of Age and Above Volume 0.5 mL

Features

AFLURIA QUADRIVALENT is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine AFLURIA QUADRIVALENT is approved for use in persons 18 years of age and older AFLURIA QUADRIVALENT is standardized according to USPHS requirements for the 2017-2018 influenza season and is formulated to contain 60 mcg hemagglutinin (HA) per 0.5 mL dose in the recommended ratio of 15 mcg HA for each of the four influenza strains recommended for the 2017-2018 Northern Hemisphere influenza season: A/Singapore/GP1908/2015 (H1N1), IVR-180A, A/Hong Kong/4801/2014 (H3N2), NYMC X-263B, B/Phuket/3073/2013 BVR-1B and B/Brisbane/46/2015